The Popular Story
  • About Us
  • Articles
  • Success Stories
  • Contact Us
  • About UsArticlesSuccess StoriesContact Us
HomeTop NewsEntertainmentSportsLifestyleAstrologyWorld
Magazine
All IssuesIconic Personalities of the Year 2026July 2026 | The Business Visionaries EditionThe Popular Story 40 Under 40Top 50 Iconic Personalities of 2026
Lists
40 Under 40Top 50 Iconic PersonalitiesIconic Personalities of the Year
Connect+
InstagramFacebookXYouTubeLinkedIn
All Categories
HomeTop NewsEntertainmentSportsLifestyleAstrologyWorldMagazine40 Under 40Top 50 Iconic PersonalitiesIconic Personalities of the YearAbout Us
Font ResizerAa
The Popular StoryThe Popular Story
Search
Follow US
Copyright © 2025-2026 MP Media. All rights reserved.
The Popular Story > Top News > Breast Cancer Breakthrough: Tata Memorial Sees New Hope in a Old Drug
Top News

Breast Cancer Breakthrough: Tata Memorial Sees New Hope in a Old Drug

By Sumitra Patel Last updated: March 25, 2025 3 Min Read
Share

Tata Memorial Centre of Mumbai has made a landmark discovery in the battle against aggressive breast cancer, especially triple-negative breast cancer (TNBC), that does not respond to standard therapies. The study, recently published, isolated a known vulnerability of TNBC cells that could make them susceptible to a known drug, a new hope for better treatment prospects.

TNBC is the most malignant type of breast cancer and is responsible for approximately 15% of all cases of breast cancer. TNBC does not express receptors for estrogen, progesterone, or HER2 and is therefore not easily targeted with hormonal or targeted therapies. This tends to make prognosis poor and treatment limited.

The Tata Memorial research team found that TNBC cells that are resistant to chemotherapy have a tendency to overexpress a particular protein that aids them in regrowing and becoming resistant to treatment. But the study revealed that these resistant cells are highly responsive to Gefitinib, a drug already used to treat lung cancer. When Gefitinib was added to Paclitaxel, a standard chemotherapy drug, the treatment proved to be more effective in stopping the regrowth of cancer cells.

Dr. Rajendra Badwe, one of the senior researchers who worked on the study, highlighted the significance of this discovery, saying that attacking this protein weakness could revolutionize the treatment of TNBC. “We found that resistant cancer cells have a special reliance on this protein, which makes them vulnerable to Gefitinib,” he said.

The research also emphasized the importance of finding biomarkers to determine which patients will most likely benefit from this combination therapy. Clinical trials will be the next step to validate its efficacy in a greater population of patients.

If successful, this breakthrough may open up a new line of treatment for TNBC, bringing hope to thousands of patients who now have limited choices. The repurposing of an approved drug such as Gefitinib may also decrease the time and expense of bringing new cancer therapies to market.

This study highlights the potential of investigating drugs already on the market for alternative applications, potentially speeding up the delivery of successful treatments for aggressive cancers. Additional research and trials are set to commence shortly, with the aim that this development will result in improved survival rates and enhanced quality of life for TNBC sufferers.

Subscribe to Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

[mc4wp_form]

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[mc4wp_form]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Email Copy Link Print
By Sumitra Patel
Follow:
Sumitra Patel is an Indian entrepreneur with an interest in business development and emerging opportunities across industries. Her professional approach reflects a focus on strategic growth, building connections and exploring new business avenues. Through her entrepreneurial journey, she continues to develop her vision and contribute to the evolving business landscape.
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SUBSCRIBE NOW

Subscribe to our newsletter to get our newest articles instantly!

[mc4wp_form]

HOT NEWS

A tulsi (holy basil) plant

Bhishma Panchak 2026: Dates, Tithi Timings, Story and Vrat Rules

Bhishma Panchak runs from 20 to 24 November 2026, the last five days of Kartik.…

November 15, 2026
A knitted woollen scarf

How to Layer Clothes for Winter: A Simple Guide for Indian Weather

Base, middle and outer layers explained for Indian winters, from foggy commutes and two-wheeler rides…

November 15, 2026
Frost on the net of a football goal

Mauricio Pochettino Named Manchester United Head Coach After Carrick Sacking

Pochettino signs until 2029 and leaves the USA job to take over a United side…

November 15, 2026

YOU MAY ALSO LIKE

Radhakishan Damani and DMart: The Quiet Investor Who Built India’s Value Retail Chain

Radhakishan Damani left the stock market in 2000 to open a supermarket. DMart now runs 518 stores. Here is how…

Success StoriesTop News
November 15, 2026

Delhi AQI Crosses 400 at Several Stations as GRAP Stage III Curbs Continue

North Campus, IIT Delhi and ITO recorded severe air on Saturday morning. GRAP Stage III remains in force, and very…

Top News
November 15, 2026

Sara Blakely and Spanx: How a Fax Machine Seller Built a Billion-Dollar Brand

Sara Blakely started Spanx in Atlanta in 2000 with $5,000 of savings and no outside investors. Here is how she…

Success StoriesTop News
November 15, 2026

Janjatiya Gaurav Diwas 2026: 246 Tribal Projects Worth Rs 3,000 Crore on Birsa Munda Jayanti

India marks Birsa Munda's 151st birth anniversary with 246 tribal projects, including 57 Eklavya schools, at a national event in…

Top News
November 15, 2026
Copyright © 2025-2026 MP Media. All rights reserved.

About Us

The Popular Story is a digital magazine and news publication bringing you stories from entertainment, sports, lifestyle, astrology and the world, with a focus on clear, original and reliable reporting.

Quick Links

  • About The Popular Story
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • Editorial Policy
  • Corrections Policy
  • Our Team

Follow us on Social Media

Explore

  • Contact Us
  • Entertainment
  • Sports
  • Lifestyle

Latest Magazine

View Magazine
© 2026 The Popular Story. All rights reserved.Privacy
Welcome Back!

Sign in to your account

Lost your password?